quantisnow
FeedTopReportsPricing
⌘K
Live feed
17:24:34·43d
SECFiling
Korro Bio Inc. logo

SEC Form SCHEDULE 13G filed by Korro Bio Inc.

KRRO· Korro Bio Inc.
Health Care
Full content unavailable. See the original source below.
Original source

Companies

  • KRRO
    Korro Bio Inc.
    Health Care

Recent analyst ratings

  • Mar 13UpdateRaymond James$23.00
  • Feb 17UpdateWilliam Blair-
  • Jan 29UpdatePiper Sandler$30.00
  • Jan 29UpdateChardan Capital Markets$15.00
  • Jan 29UpdateH.C. Wainwright$20.00
  • Jan 28UpdateCantor Fitzgerald$21.00

Related

  • PR7d
    Korro Announces Oral and Poster Presentations at Upcoming Scientific Conferences
  • SEC7d
    SEC Form DEFA14A filed by Korro Bio Inc.
  • SEC7d
    SEC Form DEF 14A filed by Korro Bio Inc.
  • PR13d
    Korro Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
  • INSIDER21d
    SEC Form 4 filed by Lynx1 Capital Management Lp
  • INSIDER21d
    SEC Form 3 filed by new insider Lynx1 Capital Management Lp
  • SEC27d
    Amendment: SEC Form SCHEDULE 13G/A filed by Korro Bio Inc.
  • SEC32d
    SEC Form EFFECT filed by Korro Bio Inc.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022